地塞米松玻璃体内植入剂治疗Vogt-Koyanagi-Harada综合征的效果
Efficacy of intravitreal dexamethasone implant in the treatment of Vogt-Koyanagi-Harada syndrome
摘要目的:评估地塞米松玻璃体内植入剂(傲迪适)治疗Vogt-Koyanagi-Harada(VKH)综合征的效果。方法:回顾性病例系列研究。纳入嘉兴中医院2020年3月至2021年2月Vogt-Koyanagi-Harada综合征的7例(14眼)中重症2例、轻中症5例。重症者均口服泼尼松8周,并于第3 d时联合地塞米松玻璃体内植入剂玻璃体内注射。轻中症患者不口服泼尼松片,余均同重症患者治疗方法。随访12个月,观察患眼注射前后最佳矫正视力(BCVA)、眼压、黄斑中心区视网膜厚度(CMT)、眼部不良反应及全身并发症的发生情况。结果:本研究所有患眼BCVA均于治疗2周后提升5行以上,玻璃体浑浊转为轻度,眼底后极部渗出性视网膜脱离基本消失,CMT重症者较治疗前降低,轻中症者较治疗前降低,后极部视网膜水肿基本消退;治疗2个月后,患者BCVA恢复正常、眼底后极部视网膜结构恢复正常;治疗10个月后所有患者病情均无反复,且均无严重并发症发生。结论:轻中症VKH单纯使用地塞米松玻璃体内植入剂注射治疗,重症者联合全身糖皮质激素口服治疗均取得了成功的初步尝试。
更多相关知识
abstractsObjective:To evaluate the efficacy of intravitreal dexamethasone implant (Ozurdex) in the treatment of Vogt-Koyanagi-Harada (VKH) syndrome.Methods:This was a retrospective case series study. Seven cases of VKH syndrome in Jiaxing Traditional Chinese Medicine Hospital from Mar. 2020 to Feb. 2021 were included. There were 2 cases of severe disease and 5 cases of mild to medium disease.In severe cases, prednisone was taken orally for 8 weeks and injected with intravitreal dexamethasone implant at the 3rd day. Patients with mild to medium disease were treated with the same treatment as severe patients except for those who did not take prednisone tablets orally. The follow-up period was 12 months and the changes of best corrected visual acuity (BCVA), intraocular pressure and central macular thickness (CMT) before and after injection, adverse eye reactions and systemic complications were observed.Results:BCVA increased by more than 5 lines, vitreous turbidity turned mild, posterior polar exudation retinal detachment basically disappeared, CMT of both severe and mild to medium patients were lower than that before treatment in all affected eyes from this study. After 2 months of treatment, BCVA returned to normal, and the posterior polar retinal structure recovered. After 10 months of treatment, there was no recurrence in all cases, and there were no serious complications.Conclusion:The mild and moderate VKH are simply treated by intravitreal dexamethasone, and the oral treatment of systemic corticosteroids in severe cases has made a successful preliminary attempt.
More相关知识
- 浏览0
- 被引2
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



